Pakistan’s Pharma Sector Poised for a Tech-Driven Future

The artificial intelligence (AI) and advanced technologies are increasingly being deployed in Pakistan’s pharma sector to improve drug development processes and detect drug reactions. This transformation is being led by industry leaders and startups, who are leveraging AI-powered tools in various ways. From predicting disease outbreaks to assisting physicians with instant access to medical information, AI-powered tools are revolutionizing the sector. Pharmaceutical companies are also using AI in pharmacovigilance, where machine learning algorithms analyze patient feedback to detect adverse drug reactions faster than ever before. Startups in Pakistan are innovating rapidly by integrating AI with telemedicine, providing more personalized treatment recommendations. For instance, PharmEvo is using telemedicine and AI chatbots like DiBot to track and connect with patients, while also launching an e-commerce platform following a direct-to-consumer (DTC) model. Industry leaders like Haroon Qasim, former Chairman of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), highlighted the transformative shift. “AI and digital technologies are steadily transforming Pakistan’s pharmaceutical sector across multiple fronts—from drug development to patient engagement, the applications are growing,” he stated.

Fruitful Applications of AI in the Pharma Sector

Some key applications of AI in the pharma sector include:

Predicting disease outbreaks: AI-powered tools now predict disease outbreaks based on prescription trends and real-time data.
Pharmacovigilance: Machine learning algorithms analyze patient feedback to detect adverse drug reactions faster than ever before.
Personalized treatment recommendations: Startups like PharmEvo are using AI to provide more personalized treatment recommendations.
E-commerce platforms: E-commerce platforms in the pharma space use predictive analytics to manage inventory, prevent stockouts, and enhance customer support.

The Integration of AI in Multiple Departments and Stages

The integration of AI spans multiple departments and stages of the pharmaceutical value chain. In research and development (R&D), AI accelerates molecule screening and optimizes drug formulation. In quality assurance, machine learning detects anomalies in production lines, improving both safety and efficiency. Regulatory affairs departments use digital tools to streamline documentation and compliance, reducing approval timelines significantly.

Department	AI Applications
R&D	Accelerate molecule screening and optimize drug formulation
Quality Assurance	Detect anomalies in production lines, improving safety and efficiency
Regulatory Affairs	Streamline documentation and compliance, reducing approval timelines

Manufacturing and Supply Chain

The integration of AI in manufacturing and supply chain is also significant. Internet of Things (IoT) systems and AI-driven automation enhance batch processing while minimizing human error. Predictive AI helps forecast demand and manage temperature-sensitive logistics.

Key Partnerships

Martin Dow Group, the country’s sixth-largest pharmaceutical company, recently hosted its first-ever Tech Day, titled AIM (Artificial Intelligence for Martin Dow). The event brought together experts from global tech giants like SAP, Salesforce, Microsoft, and PwC.

“AI is a catalyst for meaningful change,” said Ijlal Jafri, Group CIO at Martin Dow. “With our AI roadmap and today’s tech day, we take an important step towards building a smarter and more agile future where technology empowers better decisions and drives greater impact across the industry.”

These strategic moves signal the beginning of a new era in pharma-tech collaboration in Pakistan, where innovative startups and established companies are working together to create a digital healthcare ecosystem. The pharmaceutical sector in Pakistan is poised for a tech-driven future, where patient safety and efficiency are top priorities.